ASSERTIO THERAPEUTICS, INC. Additional Paid in Capital
ASSERTIO THERAPEUTICS, INC. had Additional Paid in Capital of $442.60 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2020-05-11
- 2020-03-31: Additional Paid in Capital $442.60M.
- 2019-12-31: Additional Paid in Capital $457.75M.
- 2019-09-30: Additional Paid in Capital $455.60M.
- 2019-06-30: Additional Paid in Capital $407.94M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2020-03-31 | $442.60M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $457.75M 10-Q · filed 2020-05-11 | |
| 2019-09-30 | $455.60M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $407.94M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $405.44M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $402.93M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $400.87M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $74.90M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $75.05M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $389.01M 10-K · filed 2019-03-11 | $75.16M 10-K · filed 2018-03-01 |
| 2017-09-30 | $75.71M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $75.71M 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $75.92M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $75.92M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $79.24M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $78.69M 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $78.83M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $78.62M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $80.82M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $79.07M 10-Q · filed 2015-08-03 | |
| 2015-03-31 | $77.97M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $76.81M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $75.54M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $1.85M 10-Q · filed 2014-08-06 | |
| 2014-03-31 | $1.11M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $347.00K 10-K · filed 2015-02-26 |